The trial that shows the turn
Childs, Lutz and de Wit gave healthy adults placebo, 7.5 mg or 12.5 mg of oral THC and then put them through the Trier Social Stress Test, the standard laboratory way of making someone anxious: an unprepared talk and mental arithmetic in front of an unresponsive panel.
The 7.5 mg group reported less subjective distress afterwards and appraised the task as less threatening. The 12.5 mg group reported more negative mood overall and performed worse. Same compound, same task, a five-milligram difference, opposite directions.
Why a curve that turns over matters
Almost everything confusing about THC and anxiety follows from that shape. It explains why the same person can find one dose calming and the next one frightening, why regular users and new users describe such different drugs, and why “a bit more” is the single most common way a pleasant evening goes wrong.
It also means there is no dose that is simply better. There is a dose that is better for a particular person on a particular day, and it is lower than most people guess.
What the meta-analysis found
Black and colleagues, writing in Lancet Psychiatry, pooled the randomised evidence for cannabinoids across mental disorders. Pharmaceutical THC, with or without CBD, produced a small improvement in anxiety symptoms — but only among people who had another medical condition such as chronic pain or multiple sclerosis, and the evidence was graded very low quality.
For depression the finding was blunter: scarce evidence that cannabinoids improve depressive disorders or symptoms. Their overall conclusion was that there is insufficient evidence to guide the use of cannabinoids in mental disorders within a regulatory framework.
Symptoms, and actual disorders
These are not the same thing and the distinction does most of the work. Feeling less anxious for two hours is a symptom effect. An anxiety disorder is a pattern lasting months that changes what somebody does with their life, and no trial has shown a cannabinoid altering that pattern.
It can cause what it is taken for
Acute anxiety and panic are among the most common adverse effects of THC, not rare ones, and they are dose-related. A person taking it for anxiety is taking a compound whose best-documented psychological harm is anxiety.
The panic attack, and what to do
- It is frightening and it is self-limiting. Nobody has died of it.
- Somewhere quiet, cool and familiar, with someone who knows what is happening.
- Water, and something to eat if it will go down.
- Time, which for an inhaled dose is a couple of hours and for an edible is most of a night.
Our page on what to do after too much covers the edible version, which is the harder one.
Tolerance runs the other way too
Regular use shifts the curve. A daily user is not getting the 7.5 mg experience from 7.5 mg, and the dose that reaches an effect is closer to the one that produced worse mood in the trial. This is the mechanism behind the familiar account of cannabis helping at first and then not.
Withdrawal looks exactly like anxiety
Irritability, restlessness, nervousness and sleep difficulty are all recognised features of cannabis withdrawal. For somebody using daily for anxiety, they arrive between doses and read as the anxiety returning, which is the most reliable way a helpful habit becomes a necessary one.
CBD is a different question
CBD is not intoxicating and does not have the same turning curve, which is why it is studied separately and why the two should not be reasoned about together. The trials that exist are small and used doses far above a retail serving.
The ratio on the label
Products sold as balanced, with comparable CBD and THC, are the ones users most often describe as less anxiety-provoking. The mechanism is not settled and the trials are not there, so this belongs in the column of things people report rather than things that have been shown.
Set and setting are not fluff
Expectation and surroundings measurably change what an intoxicant does, which is why the same dose can be pleasant at home and awful in a crowd. It is not a substitute for getting the dose right, and it is not nothing either.
The young brain is a separate matter
Regular cannabis use in adolescence is associated with worse mental health outcomes, and the association is strongest for early, frequent, high-potency use. Whatever the adult picture is, it does not transfer.
Psychosis risk, stated plainly
High-potency THC is associated with an increased risk of psychotic disorders, and the association is dose-related and stronger for daily use of strong material. Absolute risk for any one person is low and a family history of psychosis changes that calculation.
What potency has to do with it
Average THC content has risen substantially over recent decades, so a quantity that was a modest dose in older research is not one now. See THC percentage in cannabis for what the numbers mean.
Method changes the margin for error
Inhaled THC arrives in minutes, which makes it possible to stop. An edible arrives over an hour or two, which makes it possible to take three doses before the first one lands. For a compound whose effect reverses with dose, that is the difference that matters most.
Social anxiety, and the crowd
The stress test in that trial was social: an unprepared talk and mental arithmetic in front of a panel trained not to react. That is about as close as a laboratory gets to the situation social anxiety describes, which makes it the most transferable result on this page — and the one where the higher dose made things worse rather than better.
It is also the setting people most often reach for cannabis before, and the setting where a dose that felt fine at home lands differently.
How often it becomes a habit
A substantial minority of regular users develop a dependence syndrome, which is why the withdrawal criteria cited above needed proposing in the first place. The risk rises with frequency, with potency and with starting young.
The trap specific to this page is that the withdrawal features and the anxiety are the same features. Somebody using daily for anxiety has no clean way to tell, from the inside, which one they are feeling.
What actually has the evidence
Cognitive behavioural therapy and SSRIs have decades of randomised evidence in anxiety disorders, much of it stronger than anything on this page. That is not a reason to feel lectured; it is the comparison anyone weighing this is entitled to have in front of them.
Signs it has stopped helping
- The dose that works keeps rising.
- Gaps between doses feel like the anxiety coming back.
- It is being used before things rather than after them.
- Stopping for a week sounds harder than it should.
What to raise with a doctor
How often, how much, how strong and how long — those four answers change the advice more than anything else. Family history of psychosis matters. So does every other prescription, because THC interacts with a great many of them.
What this page will not tell you
A milligram figure for anxiety. The one controlled trial with a clean dose-response used oral capsules in a laboratory on people who were not anxious to begin with, and its own finding is that the number matters enormously and reverses within five milligrams. Nobody can responsibly translate that into a serving of something bought over a counter.
Questions people ask
Does THC help with anxiety?
It depends on the dose, and the direction reverses. In a controlled trial 7.5 mg of oral THC reduced distress after a stress task while 12.5 mg increased negative mood. The largest meta-analysis rated the anxiety evidence very low quality and found it only in people who had another medical condition.
Why does weed give me anxiety?
Because acute anxiety and panic are among the most common dose-related effects of THC. Above a person’s own turning point the compound produces the state it is often taken to relieve, and potency, tolerance and delivery method all move where that point sits.
Is THC used for depression?
The Lancet Psychiatry meta-analysis found scarce evidence that cannabinoids improve depressive disorders or symptoms, and concluded there is insufficient evidence to guide their use in mental disorders. Some trials recorded depressive symptoms worsening.
What is the right dose of THC for anxiety?
There is not an established one. The only clean dose-response trial reversed between 7.5 mg and 12.5 mg of an oral capsule, in a laboratory, in people who were not anxious to begin with. That finding argues against anyone publishing a serving size for anxiety.
Sources
- Childs E, Lutz JA, de Wit H. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend. 2017;177:136-144. accessed Sep 18, 2026
- Black N, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(12):995-1010. accessed Sep 18, 2026
- Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004;161(11):1967-1977. accessed Sep 18, 2026
- National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: National Academies Press; 2017. .gov accessed Sep 18, 2026
